Year |
Citation |
Score |
2019 |
Łaska G, Sieniawska E, Świątek Ł, Zjawiony J, Khan S, Boguszewska A, Stocki M, Angielczyk M, Polz-Dacewicz M. Phytochemistry and biological activities of Polemonium caeruleum L. Phytochemistry Letters. 30: 314-323. DOI: 10.1016/J.Phytol.2019.02.017 |
0.304 |
|
2015 |
Polepally P, Keasling A, White K, Vardy E, Mosier P, Roth B, Zjawiony J. High affinity C(2)-thiocarbonate and thioacetate-type salvinorin A ligands to the kappa-opioid receptor Planta Medica. 81. DOI: 10.1055/S-0035-1545192 |
0.337 |
|
2015 |
Polepally P, Keasling A, White K, Vardy E, Roth B, Zjawiony J. New C(2)-sulfonyl ester-type Salvinorin A ligands to the kappa-opioid receptor Planta Medica. 81. DOI: 10.1055/S-0035-1545191 |
0.353 |
|
2014 |
Polepally PR, Huben K, Vardy E, Setola V, Mosier PD, Roth BL, Zjawiony JK. Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor. European Journal of Medicinal Chemistry. 85: 818-29. PMID 25193297 DOI: 10.1055/S-0032-1307601 |
0.34 |
|
2014 |
Slominski AT, Zmijewski MA, Semak I, Zbytek B, Pisarchik A, Li W, Zjawiony J, Tuckey RC. Cytochromes p450 and skin cancer: role of local endocrine pathways. Anti-Cancer Agents in Medicinal Chemistry. 14: 77-96. PMID 23869782 DOI: 10.2174/18715206113139990308 |
0.315 |
|
2014 |
Polepally P, White K, Roth B, Zjawiony J. Design, synthesis and pharmacological activity of new C(2)-modified salvinorin A analogues Planta Medica. 80. DOI: 10.1055/S-0034-1382586 |
0.328 |
|
2013 |
Polepally P, White K, Roth B, Zjawiony J. Synthesis and In Vitro Pharmacological Activity of C-2 Modified New Salvinorin A Analogues Planta Medica. 79. DOI: 10.1055/S-0033-1336487 |
0.356 |
|
2013 |
Polepally P, Roth B, White K, Vardy E, Zjawiony J. Synthesis and Biological Evaluation of New Salvinorin B-Sulfonate Ester Ligands to Opioid Receptors Planta Medica. 79. DOI: 10.1055/S-0033-1336486 |
0.334 |
|
2012 |
Polepally P, Setola V, Vardy E, Roth B, Mosier P, Zjawiony J. New salvinorin A - Derived ligands to opioid receptors Planta Medica. 78. DOI: 10.1055/S-0032-1320925 |
0.305 |
|
2011 |
Zjawiony J, Polepally P, Roth B, Setola V, Vardy E. Design and synthesis of natural product-based ligands with high affinity to the kappa-opioid receptor Planta Medica. 77. DOI: 10.1055/S-0031-1282127 |
0.302 |
|
2010 |
Li W, Chen J, Janjetovic Z, Kim TK, Sweatman T, Lu Y, Zjawiony J, Tuckey RC, Miller D, Slominski A. Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activity. Steroids. 75: 926-35. PMID 20542050 DOI: 10.1016/J.Steroids.2010.05.021 |
0.326 |
|
2010 |
Slominski AT, Janjetovic Z, Fuller BE, Zmijewski MA, Tuckey RC, Nguyen MN, Sweatman T, Li W, Zjawiony J, Miller D, Chen TC, Lozanski G, Holick MF. Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity. Plos One. 5: e9907. PMID 20360850 DOI: 10.1371/Journal.Pone.0009907 |
0.317 |
|
2010 |
Kutrzeba LM, Li XC, Ding Y, Ferreira D, Zjawiony JK. Intramolecular transacetylation in salvinorins D and E. Journal of Natural Products. 73: 707-8. PMID 20337449 DOI: 10.1021/Np900447W |
0.726 |
|
2009 |
Carvalho P, Kutrzeba LM, Zjawiony JK, Avery MA. (2S,4aR,6aR,7R,9S,10aS,10bR)-7-Carb-oxy-2-(3-fur-yl)-6a,10b-dimethyl-4,10-dioxoperhydro-benzo[f]isochromen-9-yl acetate. Acta Crystallographica. Section E, Structure Reports Online. 65: o471-2. PMID 21582142 DOI: 10.1107/S1600536809002074 |
0.707 |
|
2009 |
Kutrzeba LM, Ferreira D, Zjawiony JK. Salvinorins J from Salvia divinorum: mutarotation in the neoclerodane system. Journal of Natural Products. 72: 1361-3. PMID 19473009 DOI: 10.1021/Np900181Q |
0.719 |
|
2009 |
Kutrzeba LM, Karamyan VT, Speth RC, Williamson JS, Zjawiony JK. In vitro studies on metabolism of salvinorin A Pharmaceutical Biology. 47: 1078-1084. DOI: 10.3109/13880200903002222 |
0.718 |
|
2008 |
Bikbulatov RV, Stewart J, Jin W, Yan F, Roth BL, Ferreira D, Zjawiony JK. Short synthesis of a novel class of salvinorin A analogs with hemiacetalic structure. Tetrahedron Letters. 49: 937-940. PMID 19197341 DOI: 10.1016/J.Tetlet.2007.12.041 |
0.549 |
|
2008 |
Tuckey RC, Janjetovic Z, Li W, Nguyen MN, Zmijewski MA, Zjawiony J, Slominski A. Metabolism of 1alpha-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1alpha,20-dihydroxyvitamin D3. The Journal of Steroid Biochemistry and Molecular Biology. 112: 213-9. PMID 19000766 DOI: 10.1016/J.Jsbmb.2008.10.005 |
0.302 |
|
2008 |
Capasso R, Borrelli F, Zjawiony J, Kutrzeba L, Aviello G, Sarnelli G, Capasso F, Izzo AA. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 20: 142-8. PMID 17931335 DOI: 10.1111/J.1365-2982.2007.00994.X |
0.704 |
|
2007 |
Kutrzeba L, Dayan FE, Howell J, Feng J, Giner JL, Zjawiony JK. Biosynthesis of salvinorin A proceeds via the deoxyxylulose phosphate pathway. Phytochemistry. 68: 1872-81. PMID 17574635 DOI: 10.1016/J.Phytochem.2007.04.034 |
0.744 |
|
2007 |
Giner JL, Kiemle DJ, Kutrzeba L, Zjawiony J. Unambiguous NMR spectral assignments of salvinorin A. Magnetic Resonance in Chemistry : Mrc. 45: 351-4. PMID 17351976 DOI: 10.1002/Mrc.1972 |
0.717 |
|
2006 |
Slominski A, Semak I, Wortsman J, Zjawiony J, Li W, Zbytek B, Tuckey RC. An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2. The Febs Journal. 273: 2891-901. PMID 16817851 DOI: 10.1111/J.1742-4658.2006.05302.X |
0.318 |
|
2006 |
Jin W, Zjawiony JK. 5-alkylresorcinols from Merulius incarnatus. Journal of Natural Products. 69: 704-6. PMID 16643059 DOI: 10.1021/Np050520D |
0.529 |
|
2006 |
Slominski A, Semak I, Wortsman J, Zjawiony J, Li W, Zbytek B, Tuckey RC. Erratum: An alternative pathway of vitamin D2 metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D 2 and 17,20-dihydroxyvitamin D2 (FEBS Journal (2006) 273 (2891-2901)) Febs Journal. 273. DOI: 10.1111/J.1742-4658.2006.05447.X |
0.301 |
|
2005 |
Slominski A, Semak I, Zjawiony J, Wortsman J, Gandy MN, Li J, Zbytek B, Li W, Tuckey RC. Enzymatic metabolism of ergosterol by cytochrome p450scc to biologically active 17alpha,24-dihydroxyergosterol. Chemistry & Biology. 12: 931-9. PMID 16125105 DOI: 10.1016/J.Chembiol.2005.06.010 |
0.351 |
|
2005 |
Slominski A, Semak I, Zjawiony J, Wortsman J, Li W, Szczesniewski A, Tuckey RC. The cytochrome P450scc system opens an alternate pathway of vitamin D3 metabolism. The Febs Journal. 272: 4080-90. PMID 16098191 DOI: 10.1111/J.1742-4658.2005.04819.X |
0.321 |
|
2004 |
Slominski A, Zjawiony J, Wortsman J, Semak I, Stewart J, Pisarchik A, Sweatman T, Marcos J, Dunbar C, C Tuckey R. A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. European Journal of Biochemistry / Febs. 271: 4178-88. PMID 15511223 DOI: 10.1111/J.1432-1033.2004.04356.X |
0.305 |
|
2004 |
Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ, Toth BA, Hufeisen SJ, Roth BL. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations. The Journal of Pharmacology and Experimental Therapeutics. 308: 1197-203. PMID 14718611 DOI: 10.1124/jpet.103.059394 |
0.516 |
|
1989 |
Wieczorek MW, Bujacz GD, Galas E, Zjawiony J, Wojciechowska A. Crystal and molecular structures of 1-(2-iso butylylcarbamoyl propan-2-ylamino) 3-(1-naphthyloxy)propan-2-ol hydrochloride (1) (C21H31N2O3Cl) and 1-(2-isobutyloxycarbonylo propan-2-ylamino) 3-(1-naphthyloxy)propan-2-ol hydrochloride (2) (C21H30NO4Cl) Journal of Crystallographic and Spectroscopic Research. 19: 967-982. DOI: 10.1007/Bf01160879 |
0.302 |
|
Show low-probability matches. |